|
Previous: KING PHARMACEUTICALS INC, S-4, EX-99.2, 2000-07-28 |
Next: KING PHARMACEUTICALS INC, S-4, EX-99.4, 2000-07-28 |
<PAGE> 1 EXHIBIT 99.3 CONSENT OF G. ANDREW FRANZ hereby consent to being named a director of King Pharmaceuticals, Inc. in the event the merger is consummated as disclosed in the Registration of King Pharmaceuticals, Inc. on Form S-4, filed with the Securities and Exchange Commission on July 27, 2000. /s/ G. ANDREW FRANZ ------------------------- G. Andrew Franz July 27, 2000
|